About New Vaccines

The first decade of the twenty first century has been the most productive in the history of new vaccine development due to the use of innovative manufacturing technology, growing support from public-private product development partnerships, and new funding resources and mechanisms. Since 2000, new life-saving vaccines include two vaccines against rotavirus; and the first conjugate vaccine against the pneumococcus bacterium.

• Countries using rotavirus, pneumococcal & HPV vaccine 2009-2012            

Meetings

• 5th Regional Pneumococcal Symposium, São, Paulo, Brazil, 2013
• Report: Lessons Learned from the Introduction of the Pneumococcal Conjugate Vaccine (PCV) In Latin America and the Caribbean, 2012
• Lecciones aprendidas con la introducción de la vacuna neumocócica conjugada (PCV): Buenos Aires, Argentina, 20-21 marzo 2012
• Simposio Regional de Nuevas Vacunas: Lima, Perú 1-3 Diciembre, 2009
• Simposio Subregional de Nuevas Vacunas: Bogota, Colombia 27-29 febrero 2008
• Simposio Subregional de Nuevas Vacunas: Caracas, Venezuela 29-30 enero 2008
• Simposio Subregional de Nuevas Vacunas: San Jose, Costa Rica 20-21 agosto 2007

Publications

• Field Guide: Rotavirus, 1st edition (2010)
• Field Guide: New Vaccines, 1st edition (2010)
• Field Guide: Pneumonia and Meningitis, 2010

Related Links

• New and Under-utilized Vaccines Implementation (NUVI)
  • General Resources 
• Immunization Newsletter